Back to search
FDAFDA · Food and drugs·Recall number D-0532-2023

MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned subsidiary of Pfizer Inc., Boulder, CO 80301. NDC: 70255-010-02

Published April 19, 2023 · Recall initiated: March 8, 2023

Summary

FDA records drug Class III recall D-0532-2023, published April 19, 2023 and initiated March 8, 2023. Recalling firm: Pfizer Inc.; Status: Ongoing; Reported quantity: 1,926 Bottles; Lot: Lot W054586A, EXP 03/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.

What to do

Voluntary: Firm initiated · Letter

Get an email if MEKTOVI has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MEKTOVI
Manufacturer
Pfizer Inc.
Distributor
Nationwide in the USA
Lot
Lot W054586A, EXP 03/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned subsidiary of Pfizer Inc., Boulder, CO 80301. NDC: 70255-010-02 recalled?

Yes. FDA published recall D-0532-2023 on April 19, 2023. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MEKTOVI.